Determination, activity and biological role of adenylosuccinate lyase in blood cells.

Adenylosuccinate lyase deficiency, which is associated with severe mental retardation and autistic features, was discovered in 1984. Since then this enzyme has been analyzed in many human tissues and it is now generally agreed that screening for this enzyme defect should be performed in all unexplained neurological diseases. The aim of the present study was to analyze adenylosuccinate lyase activity in blood cells by a fast simple method adaptable to screening purposes. The activity was also analyzed in B-lymphocytes from patients with B-cell chronic lymphocytic leukemia. The biological role of adenylosuccinate lyase and its importance in regulating cellular levels of AMP is discussed.

[1]  L. D. Smith,et al.  Adenylosuccinate lyase as an indicator of breast and prostate malignancies: a preliminary report. , 1987, Clinical biochemistry.

[2]  E. Holmes,et al.  Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme. , 1986, Arthritis and rheumatism.

[3]  C. Di Pietro,et al.  Purine nucleotide metabolism: specific aspects in chronic lymphocytic leukemia lymphocytes. , 1997, Biochimica et biophysica acta.

[4]  D. Patterson,et al.  Demonstration, by somatic cell genetics, of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jack E. Dixon,et al.  A mutation in adenylosuccinate lyase associated with mental retardation and autistic features , 1992, Nature Genetics.

[6]  M. Vincent,et al.  Adenylosuccinate lyase deficiency: an update. , 1994, Advances in experimental medicine and biology.

[7]  G. Thomas,et al.  Mapping of the human adenylosuccinate lyase (ADSL) gene to chromosome 22q13.1-->q13.2. , 1993, Cytogenetics and cell genetics.

[8]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[9]  E. Legius,et al.  Mutation analysis in adenylosuccinate lyase deficiency: Eight novel mutations in the re‐evaluated full ADSL coding sequence , 1999, Human mutation.

[10]  G Weber,et al.  Enzymes of purine metabolism in cancer. , 1983, Clinical biochemistry.

[11]  F. Bontemps,et al.  Purine nucleotide cycle, molecular defects and therapy. , 1991, Advances in experimental medicine and biology.

[12]  M. Vincent,et al.  Adenylosuccinase activity and succinylpurine production in fibroblasts of adenylosuccinase-deficient children. , 1991, Advances in experimental medicine and biology.

[13]  J. Eble,et al.  Purine enzymology of human colon carcinomas. , 1985, Cancer research.

[14]  B. Dutrillaux,et al.  Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations. , 1994, British Journal of Cancer.

[15]  W. Dinjens,et al.  Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. , 1995, European journal of biochemistry.

[16]  U. Gresser,et al.  Molecular Genetics, Biochemistry and Clinical Aspects of Inherited Disorders of Purine and Pyrimidine Metabolism , 1993, Springer Berlin Heidelberg.

[17]  Chris W. Brown,et al.  Matrix representations and criteria for selecting analytical wavelengths for multicomponent spectroscopic analysis , 1982 .

[18]  A. Ferrante,et al.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. , 1980, Journal of immunological methods.